Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Iehara

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Letters|February 19, 2002
Cytogenetic analysis of infantile neuroblastomas by comparative genomic hybridizationT Iehara, M Hamazaki, T Sawada
Medical and Pediatric Oncology|December 7, 2000
Risk of unfavorable character among neuroblastomas detected through mass screening. The Japanese Infantile Neuroblastoma Cooperative StudyT Tanaka, T Matsumura, T Iehara, et al.
The Journal of Membrane Biology|January 1, 1986
Miscibility of phosphatidylcholine binary mixtures in unilamellar vesicles: phase equilibriaN Matubayasi, T Shigematsu, T Iehara, et al.
British Journal of Cancer|January 24, 2009
RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic markerA Misawa, S Tanaka, S Yagyu, et al.
Journal of Pediatric Surgery|October 10, 2007
Continuous remission in an infant with chest wall malignant rhabdoid tumor after relapseHajime Hosoi, T Iehara, K Tsuchiya, et al.
Oncogene|November 12, 2013
PAX3-NCOA2 fusion gene has a dual role in promoting the proliferation and inhibiting the myogenic differentiation of rhabdomyosarcoma cellsH Yoshida, M Miyachi, K Sakamoto, et al.
British Journal of Cancer|May 4, 2006
MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screeningT Iehara, H Hosoi, K Akazawa, et al.
Oncogene|April 5, 2016
CD146 is a novel marker for highly tumorigenic cells and a potential therapeutic target in malignant rhabdoid tumorS Nodomi, K Umeda, S Saida, et al.
British Journal of Cancer|April 16, 2002
Experience with International Neuroblastoma Staging System and Pathology ClassificationH Ikeda, T Iehara, Y Tsuchida, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Letters|February 19, 2002
Cytogenetic analysis of infantile neuroblastomas by comparative genomic hybridizationT Iehara, M Hamazaki, T Sawada
Medical and Pediatric Oncology|December 7, 2000
Risk of unfavorable character among neuroblastomas detected through mass screening. The Japanese Infantile Neuroblastoma Cooperative StudyT Tanaka, T Matsumura, T Iehara, et al.
The Journal of Membrane Biology|January 1, 1986
Miscibility of phosphatidylcholine binary mixtures in unilamellar vesicles: phase equilibriaN Matubayasi, T Shigematsu, T Iehara, et al.
British Journal of Cancer|January 24, 2009
RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic markerA Misawa, S Tanaka, S Yagyu, et al.
Journal of Pediatric Surgery|October 10, 2007
Continuous remission in an infant with chest wall malignant rhabdoid tumor after relapseHajime Hosoi, T Iehara, K Tsuchiya, et al.
Oncogene|November 12, 2013
PAX3-NCOA2 fusion gene has a dual role in promoting the proliferation and inhibiting the myogenic differentiation of rhabdomyosarcoma cellsH Yoshida, M Miyachi, K Sakamoto, et al.
British Journal of Cancer|May 4, 2006
MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screeningT Iehara, H Hosoi, K Akazawa, et al.
Oncogene|April 5, 2016
CD146 is a novel marker for highly tumorigenic cells and a potential therapeutic target in malignant rhabdoid tumorS Nodomi, K Umeda, S Saida, et al.
British Journal of Cancer|April 16, 2002
Experience with International Neuroblastoma Staging System and Pathology ClassificationH Ikeda, T Iehara, Y Tsuchida, et al.
Pageof 1